<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for The Rossington Practice</h1>
        <p>There is substantial variation in prescribing behaviours, across various different areas of medicine. Some variation can be explained by demographic changes, or local policies or guidelines, but much of the remaining variation is less easy to
            explain. At <a href="https://openprescribing.net/">OpenPrescribing</a> we are piloting a number of data-driven approaches to identify unusual prescribing and collect feedback on this prescribing to inform development of new tools to support
            prescribers and organisations to audit and review prescribing.</p>
        <p>This report has been developed to automatically identify prescribing patterns at a chemical level which are furthest away from “typical prescribing” and can be classified as an “outlier”. We calculate the number of prescriptions for each chemical
            in the <a href="https://www.thedatalab.org/blog/161/prescribing-data-bnf-codes">BNF coding system</a> using the BNF subparagraph as a denominator, for prescriptions dispensed between April 2021 and August 2021. We then calculate the
            mean and standard deviation for each numerator and denominator pair across all practices/CCGs/PCNs/STPs. From this we can calculate the “z-score”, which is a measure of how many standard deviations a given practice/CCG/PCN/STP is from the
            population mean. We then rank your “z-scores” to find the top 5 results where prescribing is an outlier for prescribing higher than its peers and those where it is an outlier for prescribing lower than its peers.
        </p>
        <p>It is important to remember that this information was generated automatically and it is therefore likely that some of the behaviour is warranted. This report seeks only to collect information about where this variation may be warranted and where
            it might not. Our full analytical method code is openly available on GitHub <a href="https://github.com/ebmdatalab/outliers/">here</a>.
        </p>
        <p>The DataLab is keen to hear your feedback on the results. You can do this by completing the following <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=practice+C86015">survey</a>            or emailing us at <a href="mailto:ebmdatalab@phc.ox.ac.uk?subject=OpenPrescribing%20outliers%20feedback">ebmdatalab@phc.ox.ac.uk</a>. Please DO NOT INCLUDE IDENTIFIABLE PATIENT information in your feedback. All feedback is helpful, you can
            send short or detailed feedback.
        </p>
        <h2>Prescribing where The Rossington Practice is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0601012AB&amp;denomIds=6.1.1&amp;selectedTab=summary">Insulin glargine/lixisenatide</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>20</td>
      <td>Intermediate and long-acting insulins</td>
      <td>500</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>27.61</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0601012ABBBAAAA&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Suliqua 100units/ml / 33microg/ml inj 3ml pf SoloStar pens : 15</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0601012ABAAABAB&amp;denomIds=6.1.1&amp;selectedTab=summary" target="_blank">Ins glargine 100u/ml / Lixis 50mcg/ml inj 3ml pf dispos dev : 5</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0704050AD&amp;denomIds=7.4.5&amp;selectedTab=summary">Phentolamine/aviptadil</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>10</td>
      <td>Drugs for erectile dysfunction</td>
      <td>273</td>
      <td>0.04</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>8.50</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0704050ADAAAAAA&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Phentolamine 2mg/0.35ml / Aviptadil 25microg/0.35ml inj amp : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0704050ADBBAAAA&amp;denomIds=7.4.5&amp;selectedTab=summary" target="_blank">Invicorp 25micrograms/2mg/0.35ml inj : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=1302020B0&amp;denomIds=13.2.2&amp;selectedTab=summary">Benzalkonium chloride</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>11</td>
      <td>Barrier preparations</td>
      <td>11</td>
      <td>1.00</td>
      <td>0.05</td>
      <td>0.14</td>
      <td>6.69</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=1302020B0BBAAAB&amp;denomIds=13.2.2&amp;selectedTab=summary" target="_blank">Drapolene cream : 11</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=1003020W0&amp;denomIds=10.3.2&amp;selectedTab=summary">Heparinoid</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>163</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>559</td>
      <td>0.29</td>
      <td>0.03</td>
      <td>0.05</td>
      <td>5.74</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=1003020W0AAAAAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% gel : 133</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=1003020W0AAABAB&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Salicylic acid 2% / Mucopolysaccharide polysulfate 0.2% crm : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=1003020W0BBABAA&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Movelat gel : 19</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0205052AB&amp;denomIds=2.5.5&amp;selectedTab=summary">Olmesartan medoxomil/amlodipine</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>21</td>
      <td>Angiotensin-II receptor antagonists</td>
      <td>1251</td>
      <td>0.02</td>
      <td>0.00</td>
      <td>0.00</td>
      <td>5.03</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0205052ABAAAAAA&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Olmesartan medoxomil 20mg / Amlodipine 5mg tablets : 16</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0205052ABAAACAC&amp;denomIds=2.5.5&amp;selectedTab=summary" target="_blank">Olmesartan medoxomil 40mg / Amlodipine 10mg tablets : 5</a></div></td></tr></tbody></table>

        <h2>Prescribing where The Rossington Practice is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribed item count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0607010C0&amp;denomIds=6.7.1&amp;selectedTab=summary">Cabergoline</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Bromocriptine and other dopaminergic drugs</td>
      <td>6</td>
      <td>0.17</td>
      <td>0.86</td>
      <td>0.27</td>
      <td>-2.55</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0607010C0AAAAAA&amp;denomIds=6.7.1&amp;selectedTab=summary" target="_blank">Cabergoline 500microgram tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0601040I0&amp;denomIds=6.1.4&amp;selectedTab=summary">Glucose</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Treatment of hypoglycaemia</td>
      <td>12</td>
      <td>0.25</td>
      <td>0.75</td>
      <td>0.21</td>
      <td>-2.42</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0601040I0AAADAD&amp;denomIds=6.1.4&amp;selectedTab=summary" target="_blank">Glucose 40% oral gel : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0202010P0&amp;denomIds=2.2.1&amp;selectedTab=summary">Indapamide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>82</td>
      <td>Thiazides and related diuretics</td>
      <td>1288</td>
      <td>0.06</td>
      <td>0.42</td>
      <td>0.16</td>
      <td>-2.26</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0202010P0AAAAAA&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 2.5mg tablets : 34</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0202010P0AAADAD&amp;denomIds=2.2.1&amp;selectedTab=summary" target="_blank">Indapamide 1.5mg modified-release tablets : 48</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=130201100&amp;denomIds=13.2.1&amp;selectedTab=summary">Emollient bath and shower preparations</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>27</td>
      <td>Emollient bath and shower preparations</td>
      <td>156</td>
      <td>0.17</td>
      <td>0.61</td>
      <td>0.21</td>
      <td>-2.07</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=130201100BBAEAA&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Balneum 84.75% bath oil : 4</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=130201100AAAMAM&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Aqueous cream : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=130201100BBAAAE&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">E45 emollient bath oil : 3</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=130201100BBAZAN&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 200 shower emollient : 11</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=130201100BBAQA0&amp;denomIds=13.2.1&amp;selectedTab=summary" target="_blank">Dermol 600 bath emollient : 6</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0&amp;denomIds=3.1.2&amp;selectedTab=summary">Tiotropium bromide</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>159</td>
      <td>Antimuscarinic bronchodilators</td>
      <td>461</td>
      <td>0.34</td>
      <td>0.71</td>
      <td>0.18</td>
      <td>-1.99</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0AAABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation powder capsules : 99</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0BBACAC&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln : 35</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0BBABAB&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva 18microgram inhalation powder capsules : 2</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0AAAAAA&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Tiotropium bromide 18microgram inhalation pdr caps with dev : 9</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0BBADAE&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Spiriva Respimat 2.5microg/dose inhalation soln refill cart : 7</a><br><a href="https://openprescribing.net/analyse/#org=practice&amp;orgIds=C86015&amp;numIds=0301020Q0BCAAAD&amp;denomIds=3.1.2&amp;selectedTab=summary" target="_blank">Braltus 10microgram inhalation pdr caps with Zonda inhaler : 7</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>